Study Shows HIV Remission Is Possible for Children Started on Very Early Antiretroviral Therapy

Research co-led by an investigator at Johns Hopkins Children’s Center shows that four children born with HIV who were safely removed from antiretroviral therapy (ART) continued to have undetectable levels of the virus for about a year or more without treatment. The children were among 54 newborns who were given very early treatment within the first 48 hours of life — rather than within weeks or months, as is typical.
[email protected]

Childhood Cancer Awareness Month Has Special Meaning for Johns Hopkins Children’s Center Pediatric Oncology Nurse

For the past three years, nurse Lauren Chelenza has cared for hundreds of children with cancer while working on the pediatric oncology inpatient unit at Johns Hopkins Children’s Center in Baltimore. It’s a place she never imagined she’d be working 15 years ago, while going through her own cancer treatment.

Kentucky physician explores new pediatric care protocols in developing nations

George Fuchs, M.D., a pediatric gastroenterologist at Kentucky Children’s Hospital, conducted a years-long trial in Bangladesh testing a model of healthcare delivery for children with pneumonia. The results have the potential to change pediatric care in developing nations.

Hackensack Meridian Children’s Health Hospitals Earn Top Ranking for Third Year in a Row in U.S. News & World Report’s 2023-24 Best Children’s Hospitals List

Hackensack Meridian Health, New Jersey’s largest, most comprehensive hospital network, is proud to announce that the Hackensack Meridian Joseph M. Sanzari and K. Hovnanian Children’s Hospitals – filed jointly under a single program – are ranked #1 in New Jersey for the third year in a row, and #10 in the Mid-Atlantic Region in the U.S. News & World Report Best Children’s Hospitals 2023-23 Rankings.

Advancing Care and Innovation for Pediatric Brain Tumors

The Brain Tumor Center at Children’s Hospital Los Angeles takes a team approach—and offers one of the largest clinical trial programs of its kind. The Brain Tumor Center at Children’s Hospital Los Angeles is one of the largest and most comprehensive pediatric brain tumor programs in the country, integrating experts from multiple specialty areas into a coordinated treatment team.

Ace High School Pitcher Thriving Despite Hydrocephalus

CHLA is at the forefront of research into endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) as part of a clinical trial funded by the Hydrocephalus Clinical Research Network (HCRN), a network of 14 pediatric neurosurgery centers that includes Children’s Hospital Los Angeles. The trial, titled “Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants,” is evaluating the effectiveness of shunts versus ETV-CPC in infants with hydrocephalus.

What You Should Know About Mpox

Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.

Children’s Hospital Los Angeles Receives $2.8 Million Award to Use AI to Predict Precision Dosing for Critically Ill Children

Artificial intelligence could help doctors dynamically determine safe and effective medication dosing for unstable ICU patients. Predicting the right dose of medication that a critically ill child in the ICU will require in the future is a huge challenge for clinicians. FDA prescribing guidelines generally assume that patients are stable enough so that dosing for a given group is usually unchanged during treatment, but this ‘one size fits all’ approach to medication dosing does not accurately target the condition of each individual patient over time.

Can Butyrate Help Hispanic Children With Ulcerative Colitis?

New study is the first of its kind to focus on Hispanic children, who often have more severe disease. A novel clinical trial at Children’s Hospital Los Angeles is investigating whether butyrate—a short-chain fatty acid typically produced by gut bacteria—can be a potential therapy for children with ulcerative colitis.

Chief of Critical Care at University of Maryland Children’s Hospital available to discuss RSV and “tripledemic”

With an early influx of viral respiratory admissions already straining capacity, children’s hospitals are girding themselves for cases to rise in the weeks ahead. Available to discuss how RSV and other respiratory viruses can land a child in the hospital…

From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma

New research led by Kara Kelly, MD, of Roswell Park Comprehensive Cancer Center and presented today at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago shows that a combination of brentuximab vedotin (Bv) and standard chemotherapy is safe and more effective than standard chemotherapy in pediatric patients up to age 21 years with newly diagnosed high-risk Hodgkin lymphoma. The findings from a phase 3 National Cancer Institute-supported multicenter Children’s Oncology Group clinical trial (NCT 02166463) were presented by first author Sharon Castellino, MD, of Emory University and Children’s Healthcare of Atlanta in an oral abstract session on Friday, June 3.

Four Things to Know About the Infant Formula Shortage Right Now

Tips from a clinical dietitian for keeping babies healthy when formula is in short supply. It’s no secret the COVID pandemic has brought with it a spate of supply chain challenges. The latest product in crisis: infant and child formula.The shortage has affected nearly all types of formulas, hitting those who require special formulas the hardest: children with milk allergies, developmental disabilities and special needs, among other conditions.

Keeping an Eye on Your Child’s Vision: Ten Things to Know

Children’s Hospital Los Angeles answers 10 FAQs to help you safeguard your kid’s eyesight, and to know when it’s time to get it checked. From allergies to nearsightedness, to the daily staring at digital screens, the hazards facing kids’ eyes give parents a lot to worry about. Angeline Nguyen, MD, a pediatric ophthalmologist in The Vision Center at CHLA, breaks down the concerns you may have about your child’s vision, including the reason behind increased nearsightedness in kids, whether too much screen time can harm their eyes, and whether your child can outgrow the need for glasses.

Gun Violence Exposure Associated with Higher Rates of Mental Health-Related ED Visits by Children

Exposure to neighborhood gun violence is associated with increased odds of mental health-related pediatric Emergency Department (ED) visits among children living within four to five blocks of a shooting, according to research by the Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia, published today in JAMA Pediatrics.

UK HealthCare Launches Pediatric Neuroendocrine Tumor Program

UK HealthCare recently launched a new Pediatric Neuroendocrine Tumor Clinical and Research Program to improve treatment for children diagnosed with or at high risk for developing rare neuroendocrine tumors (NETs). This program is a joint effort between the University of Kentucky Markey Cancer Center and the Kentucky Children’s Hospital and is one of only a handful of centers specializing in this field in the world.

Nationwide Children’s Hospital Prioritizes Kindergarten Readiness as Part of Pediatric “Vital Signs”

Five and six-year-olds across the country are currently being evaluated for kindergarten readiness, a measurement of a child’s ability to engage with standard kindergarten curriculum. Nationwide Children’s Hospital is helping kids get ready for kindergarten locally with the hopes of researching outcomes and helping other systems adopt education as an important part of health care delivery.

Can Doctors Predict Which Children with Pneumonia Will Develop Mild or Severe Disease?

Currently, there are no evidence-based rules that help physicians in the Emergency Department (ED) predict if a child with community-acquired pneumonia will have a mild disease course that can be treated at home or a more severe illness that requires hospitalization. A recent study published in the journal Pediatrics found that the predictive accuracy of clinical judgement was generally fair, but clinicians were least accurate when predicting progression to severe disease in children initially classified as having “low to moderate” risk, which accounts for a large portion of children presenting with pneumonia.

Virtual Health Pilot Program Expands for Salado ISD Students and Families

The innovative virtual health pilot program is designed to facilitate care for elementary and middle school students by connecting the school nurse, the child’s parent or guardian, and a Baylor Scott & White McLane Children’s Medical Center provider via a video visit.

First targeted therapy for children with achondroplasia shows persistent height gain for up to two years

Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society’s annual meeting.

MicroRNA Testing of Healthy Children Could Provide a Window on Heart and Kidney Health Later in Life

Molecules called microRNAs (miRNAs) that are measurable in urine have been identified by researchers at Mount Sinai as predictors of both heart and kidney health in children without disease. The epidemiological study of Mexican children was published in February in the journal Epigenomics.

Simulation Helps Refine Pediatric Care Guidelines For COVID-19

DALLAS – Jan. 28, 2021 – Simulation can be a viable way to quickly evaluate and refine new medical guidelines and educate hospital staff in new procedures, a recent study from UT Southwestern’s Department of Pediatrics shows. The findings, published recently in the journal Pediatric Quality and Safety and originally shaped around new COVID-19-related pediatric resuscitation procedures at UTSW and Children’s Health, could eventually be used to help implement other types of guidelines at medical centers nationwide.